Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2

This is a preview of subscription content, log in to check access.

Fig. 3
Fig. 1
Fig. 2
Fig. 4

References

  1. 1.

    Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569–78.

    CAS  Article  Google Scholar 

  2. 2.

    Trotta L, Martelius T, Siitonen T, Hautala T, Hämäläinen S, Juntti H, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141:1534–1537.e8.

    Article  Google Scholar 

  3. 3.

    Alabbas F, Elyamany G, Alsharif O, Hershfield M, Meyts I. Childhood Hodgkin lymphoma: think DADA2. J Clin Immunol. 2019;39:26–9.

    Article  Google Scholar 

  4. 4.

    Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol Rev. 2019;291:174–89.

    CAS  Article  Google Scholar 

  5. 5.

    Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88:279–90.

    CAS  Article  Google Scholar 

  6. 6.

    Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci CMLS. 2017;74:555–70.

    CAS  Article  Google Scholar 

  7. 7.

    Arts K, Bergerson JRE, Ombrello AK, Similuk M, Oler AJ, Agharahimi A, et al. Warts and DADA2: a mere coincidence? J Clin Immunol. 2018;38:836–43.

    Article  Google Scholar 

  8. 8.

    Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, et al. The genetic landscape of Diamond-Blackfan anemia. Am J Hum Genet. 2018;103:930–47.

    CAS  Article  Google Scholar 

  9. 9.

    Hashem H, Kumar AR, Müller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130:2682–8.

    CAS  Article  Google Scholar 

  10. 10.

    Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39:e293–6.

    Article  Google Scholar 

  11. 11.

    Rosain J, Oleaga-Quintas C, Deswarte C, Verdin H, Marot S, Syridou G, et al. A variety of Alu-mediated copy number variations can underlie IL-12Rβ1 deficiency. J Clin Immunol. 2018;38:617–27.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

T. L. V. and D. B wrote the manuscript. G. L. G and F. S. contributed to the patient recruitment and management. D. B. and S. L. performed the exome analysis. G. B. performed identification of the large deletion and intra-familial segregation analysis. A. L. reviewed pathological specimen. D. B., S. L., and G. L. G supervised the project. All the authors reviewed the manuscript.

Corresponding authors

Correspondence to David Boutboul or Guillaume Le Guenno.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Le Voyer, T., Boutboul, D., Ledoux-Pilon, A. et al. Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2. J Clin Immunol 40, 948–953 (2020). https://doi.org/10.1007/s10875-020-00812-8

Download citation